AZD4547

  • Purchase Qty: 1 5
  • Unit: g(s) g(s)
  • Fob Unit Price: US $250 US $900
  • Payment Terms:T/T , PayPal
  • Favorite
Shanghai Caerulum Pharma Discovery

Business Type:Manufacturer

Country/Region:China

Ddu Verified

HOT Rank

6/10

Product Information

  • CAS:1035270-39-3
  • Active Ingredients:N-(5-(3,5-dimethoxyphenethyl)-4H-pyrazol-3-yl)-4-((3S,5R)-3,5-dimethylpiperazin-1-yl)benzamide
  • Chemical Formula:C26H33N5O3
  • Molecular Weight:463.57
  • Assay:min 98%
  • Pharmacopeia:CP
  • Shelf Life:2 years
  • Storage:Sealed
  • Place of Origin:China

Description

AZD4547 is an orally bioavailable inhibitor of the fibroblast growth factor receptor (FGFR) with potential antineoplastic activity. FGFR inhibitor AZD4547 binds to and inhibits FGFR, which may result in the inhibition of FGFR-related signal transduction pathways, and, so, the inhibition of tumor cell proliferation and tumor cell death. FGFR, up-regulated in many tumor cell types, is a receptor tyrosine kinase essential to tumor cellular proliferation, differentiation and survival.


Shanghai Caerulum Pharma Discovery is the manufacturer of APIs and intermediates of some of the latest compounds in the market. Our focus is on cancer, diabetes and other therapeutic areas.

 

Shanghai Caerulum Pharma Discovery (CPD) offers high quality and reliable chemical products and integrated biological services including:

1)       Best offer for existing APIs and intermediates

2)       Custom-synthesis APIs and intermediates

3)       DMPK

4)       Biological screening

5)       Drug Safety Evaluation


You Might Also Like
Change a group
Inquiry Cart(0)